Skip to main content
. 2014 Sep 9;5(20):9811–9822. doi: 10.18632/oncotarget.2443

Figure 1. Treatment scheme.

Figure 1

(A.) Engraftment of intracranial tumors was confirmed by serial BLI over the two week post implantation period. (B) A subcutaneous osmotic pump delivered either PBS or POL5551 (low dose or high dose) continuously over 28 days. Mice received either mcr84 or vehicle IgG antibody (10 mg/kg i.p. twice weekly for 4 weeks).